Evoke Pharma, Inc. (EVOK)

USD 2.11

(-10.21%)

Total Assets Summary of Evoke Pharma, Inc.

  • Evoke Pharma, Inc.'s latest annual total assets in 2023 was 7.06 Million USD , down -40.36% from previous year.
  • Evoke Pharma, Inc.'s latest quarterly total assets in 2024 Q2 was 12.13 Million USD , down -2.55% from previous quarter.
  • Evoke Pharma, Inc. reported annual total assets of 11.85 Million USD in 2022, up 12.09% from previous year.
  • Evoke Pharma, Inc. reported annual total assets of 10.57 Million USD in 2021, up 12.07% from previous year.
  • Evoke Pharma, Inc. reported quarterly total assets of 12.13 Million USD for 2024 Q2, down -2.55% from previous quarter.
  • Evoke Pharma, Inc. reported quarterly total assets of 8.97 Million USD for 2023 Q2, down -10.55% from previous quarter.

Annual Total Assets Chart of Evoke Pharma, Inc. (2023 - 2011)

Historical Annual Total Assets of Evoke Pharma, Inc. (2023 - 2011)

Year Total Assets Total Assets Growth
2023 7.06 Million USD -40.36%
2022 11.85 Million USD 12.09%
2021 10.57 Million USD 12.07%
2020 9.43 Million USD 47.51%
2019 6.39 Million USD 13.0%
2018 5.65 Million USD -28.73%
2017 7.94 Million USD -14.55%
2016 9.29 Million USD -2.5%
2015 9.53 Million USD -37.7%
2014 15.3 Million USD -38.76%
2013 24.98 Million USD 21437.64%
2012 116.01 Thousand USD -87.19%
2011 905.33 Thousand USD 0.0%

Peer Total Assets Comparison of Evoke Pharma, Inc.

Name Total Assets Total Assets Difference
ANI Pharmaceuticals, Inc. 904.42 Million USD 99.218%
Aquestive Therapeutics, Inc. 57.41 Million USD 87.689%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 99.382%
Dynavax Technologies Corporation 997.09 Million USD 99.291%
Esperion Therapeutics, Inc. 205.79 Million USD 96.565%
Cosmos Health Inc. 66.29 Million USD 89.338%
Pacira BioSciences, Inc. 1.57 Billion USD 99.551%
PainReform Ltd. 9.93 Million USD 28.816%
Sunshine Biopharma, Inc. 27.34 Million USD 74.152%
Sunshine Biopharma, Inc. 27.34 Million USD 74.152%
SCYNEXIS, Inc. 128.41 Million USD 94.495%
Safety Shot Inc 12.7 Million USD 44.382%
China SXT Pharmaceuticals, Inc. 23.12 Million USD 69.436%
Alpha Teknova, Inc. 128.58 Million USD 94.503%
Embecta Corp. 1.21 Billion USD 99.418%
Bright Green Corporation 17.4 Million USD 59.383%
Intra-Cellular Therapies, Inc. 728.29 Million USD 99.029%
Journey Medical Corporation 76.84 Million USD 90.802%
Procaps Group, S.A. 460.18 Million USD 98.464%
Theratechnologies Inc. 77.76 Million USD 90.911%
Harrow Health, Inc. 311.75 Million USD 97.733%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD 52.538%
Biofrontera Inc. 27.93 Million USD 74.694%
DURECT Corporation 45.18 Million USD 84.358%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 99.498%
Cronos Group Inc. 1.13 Billion USD 99.377%
OptiNose, Inc. 107.72 Million USD 93.439%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 98.499%
Kala Pharmaceuticals, Inc. 55.94 Million USD 87.366%
RedHill Biopharma Ltd. 23.04 Million USD 69.33%
Organogenesis Holdings Inc. 460.02 Million USD 98.463%
Guardion Health Sciences, Inc. 11.91 Million USD 40.691%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 91.356%
Radius Health, Inc. 1.71 Billion USD 99.588%
Universe Pharmaceuticals INC 53.28 Million USD 86.735%
ProPhase Labs, Inc. 91.92 Million USD 92.311%
Phibro Animal Health Corporation 982.18 Million USD 99.28%
Procaps Group S.A. 460.18 Million USD 98.464%
Alvotech 950.09 Million USD 99.256%
TherapeuticsMD, Inc. 43.3 Million USD 83.679%
Viatris Inc. 47.68 Billion USD 99.985%
Rockwell Medical, Inc. 52.17 Million USD 86.452%
Aytu BioPharma, Inc. 118.09 Million USD 94.015%
SIGA Technologies, Inc. 254.83 Million USD 97.226%
Tilray Brands, Inc. 4.33 Billion USD 99.837%
Lifecore Biomedical, Inc. 273.7 Million USD 97.417%
Shineco, Inc. 84.17 Million USD 91.603%
PetIQ, Inc. 868.22 Million USD 99.186%
Regencell Bioscience Holdings Limited 8.43 Million USD 16.232%
Incannex Healthcare Limited 17.04 Million USD 58.535%
Neurocrine Biosciences, Inc. 3.25 Billion USD 99.783%
Alimera Sciences, Inc. 153.52 Million USD 95.396%
Silver Spike Investment Corp. 88.57 Million USD 92.02%
Assertio Holdings, Inc. 286.41 Million USD 97.532%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -18.764%
Petros Pharmaceuticals, Inc. 33.79 Million USD 79.085%
Clever Leaves Holdings Inc. 31.24 Million USD 77.376%
Cyclo Therapeutics, Inc. 13.24 Million USD 46.643%
Avadel Pharmaceuticals plc 261.12 Million USD 97.293%
Hempacco Co., Inc. 18.04 Million USD 60.824%
Talphera, Inc. 20.39 Million USD 65.342%
Alvotech 950.09 Million USD 99.256%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 98.26%
Lantheus Holdings, Inc. 1.65 Billion USD 99.572%
Currenc Group, Inc. 141.49 Million USD 95.004%
Kamada Ltd. 351.96 Million USD 97.992%
Indivior PLC 1.95 Billion USD 99.638%
Flora Growth Corp. 23.62 Million USD 70.081%
Cyclo Therapeutics, Inc. 13.24 Million USD 46.643%
Evolus, Inc. 188.99 Million USD 96.26%
HUTCHMED (China) Limited 1.27 Billion USD 99.448%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 99.533%
Akanda Corp. 8.83 Million USD 20.039%